Sensorion to Participate in March Investor Conferences

Sensorion, a clinical-stage biotechnology company focused on therapies for hearing loss disorders, has announced its participation in several investor conferences in March. This involvement is part of the company's efforts to engage with stakeholders and showcase its progress in developing therapies for hearing-related conditions.

Key company figures, CEO Nawal Ouzren and CFO Laurene Danon, will represent Sensorion in the events, including the Cowen’s 45th Annual Health Care Conference in Boston and Leerink’s Partners Global Healthcare Conference in Miami. Both events provide opportunities for one-on-one meetings and presentations, allowing investors to gain insights into Sensorion's strategies and goals.

The participation of Sensorion's leadership underlines the company's commitment to fostering relationships with the investor community, as it continues to develop innovative solutions for significant unmet medical needs in hearing health.